Catalyst Wire Dossier Catalyst Wire Dossier

Megavec 400 mg

Imatinib Mesylate · Daewoong Pharmaceutical Co. LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Megavec 400 mg, covering 2012-07-31 to 2012-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers [Phase 1]

See pricing